Federal lawmakers are scrutinizing Pfizer and Eli Lilly's direct-to-consumer telehealth platforms in search of any indication the services could create conflicts of interest for prescribers, Fierce Pharma Marketing reported. Those lawmakers are now directing similar queries toward several of the platforms' partners. The legislators sent letters to five telehealth companies that have held contracts with Lilly or Pfizer: 9amHealth, Thirty Madison, Form Health, Populus Health Technologies and UpScriptHealth.